These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8419601)

  • 1. Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.
    Boucher FD; Modlin JF; Weller S; Ruff A; Mirochnick M; Pelton S; Wilfert C; McKinney R; Crain MJ; Elkins MM
    J Pediatr; 1993 Jan; 122(1):137-44. PubMed ID: 8419601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.
    McKinney RE; Pizzo PA; Scott GB; Parks WP; Maha MA; Lehrman SN; Riggs M; Eddy J; Lane BA; Eppes SC
    J Pediatr; 1990 Apr; 116(4):640-7. PubMed ID: 2181102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tolerance of zidovudine in preterm infants.
    Capparelli EV; Mirochnick M; Dankner WM; Blanchard S; Mofenson L; McSherry GD; Gay H; Ciupak G; Smith B; Connor JD;
    J Pediatr; 2003 Jan; 142(1):47-52. PubMed ID: 12520254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
    McKinney RE; Maha MA; Connor EM; Feinberg J; Scott GB; Wulfsohn M; McIntosh K; Borkowsky W; Modlin JF; Weintrub P
    N Engl J Med; 1991 Apr; 324(15):1018-25. PubMed ID: 1672443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group.
    O'Sullivan MJ; Boyer PJ; Scott GB; Parks WP; Weller S; Blum MR; Balsley J; Bryson YJ
    Am J Obstet Gynecol; 1993 May; 168(5):1510-6. PubMed ID: 8098905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.
    Balis FM; Pizzo PA; Eddy J; Wilfert C; McKinney R; Scott G; Murphy RF; Jarosinski PF; Falloon J; Poplack DG
    J Pediatr; 1989 May; 114(5):880-4. PubMed ID: 2715903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection.
    Husson RN; Mueller BU; Farley M; Woods L; Kovacs A; Goldsmith JC; Ono J; Lewis LL; Balis FM; Brouwers P
    Pediatrics; 1994 Feb; 93(2):316-22. PubMed ID: 7907174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection.
    Sperling RS; Stratton P; O'Sullivan MJ; Boyer P; Watts DH; Lambert JS; Hammill H; Livingston EG; Gloeb DJ; Minkoff H
    N Engl J Med; 1992 Mar; 326(13):857-61. PubMed ID: 1542322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.
    MMWR Recomm Rep; 1994 Aug; 43(RR-11):1-20. PubMed ID: 7913986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand.
    Briand N; Le Coeur S; Jourdain G; Hotrawarikarn S; Sirinontakan S; Hinjiranandana T; Kanjanavanit S; Traisathit P; McIntosh K; Lallemant M;
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1163-6. PubMed ID: 20854205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants.
    Rodman JH; Flynn PM; Robbins B; Jimenez E; Bardeguez AD; Rodriguez JF; Blanchard S; Fridland A
    J Infect Dis; 1999 Dec; 180(6):1844-50. PubMed ID: 10558940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
    JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
    Bhana N; Ormrod D; Perry CM; Figgitt DP
    Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.
    Fiscus SA; Adimora AA; Schoenbach VJ; Lim W; McKinney R; Rupar D; Kenny J; Woods C; Wilfert C
    JAMA; 1996 May; 275(19):1483-8. PubMed ID: 8622222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of zidovudine administered by continuous infusion in children.
    Balis FM; Pizzo PA; Murphy RF; Eddy J; Jarosinski PF; Falloon J; Broder S; Poplack DG
    Ann Intern Med; 1989 Feb; 110(4):279-85. PubMed ID: 2643914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
    Alimenti A; Burdge DR; Ogilvie GS; Money DM; Forbes JC
    Pediatr Infect Dis J; 2003 Sep; 22(9):782-9. PubMed ID: 14506368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group.
    Lipshultz SE; Easley KA; Orav EJ; Kaplan S; Starc TJ; Bricker JT; Lai WW; Moodie DS; Sopko G; McIntosh K; Colan SD
    N Engl J Med; 2000 Sep; 343(11):759-66. PubMed ID: 10984563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.